BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1284 related articles for article (PubMed ID: 18057991)

  • 1. Prognosis of perihilar cholangiocarcinoma: hilar bile duct cancer versus intrahepatic cholangiocarcinoma involving the hepatic hilus.
    Sano T; Shimada K; Sakamoto Y; Ojima H; Esaki M; Kosuge T
    Ann Surg Oncol; 2008 Feb; 15(2):590-9. PubMed ID: 18057991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):311-6. PubMed ID: 11995440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.
    Ito F; Agni R; Rettammel RJ; Been MJ; Cho CS; Mahvi DM; Rikkers LF; Weber SM
    Ann Surg; 2008 Aug; 248(2):273-9. PubMed ID: 18650638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients.
    Rea DJ; Munoz-Juarez M; Farnell MB; Donohue JH; Que FG; Crownhart B; Larson D; Nagorney DM
    Arch Surg; 2004 May; 139(5):514-23; discussion 523-5. PubMed ID: 15136352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic factors and long term outcome after surgery for hilar cholangiocarcinoma. Univariate and multivariate analysis].
    Ramacciato G; Di Benedetto F; Cautero N; Masetti M; Mercantini P; Corigliano N; Nigri G; Lauro A; Ercolani G; Del Gaudio M; De Ruvo N; Pinna AD
    Chir Ital; 2004; 56(6):749-59. PubMed ID: 15771027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hepatic resection margin on recurrence and survival in intrahepatic cholangiocarcinoma.
    Tamandl D; Herberger B; Gruenberger B; Puhalla H; Klinger M; Gruenberger T
    Ann Surg Oncol; 2008 Oct; 15(10):2787-94. PubMed ID: 18685896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma.
    Jan YY; Jeng LB; Hwang TL; Wang CS; Chen MF; Chen TJ
    Hepatogastroenterology; 1996; 43(9):614-9. PubMed ID: 8799405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
    Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma.
    Li SQ; Liang LJ; Hua YP; Peng BG; He Q; Lu MD; Chen D
    Chin Med J (Engl); 2009 Oct; 122(19):2286-91. PubMed ID: 20079127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.
    Murakami Y; Uemura K; Hayashidani Y; Sudo T; Hashimoto Y; Ohge H; Sueda T
    J Surg Oncol; 2007 Mar; 95(3):207-12. PubMed ID: 17278119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
    Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
    Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
    Nakagohri T; Asano T; Kinoshita H; Kenmochi T; Urashima T; Miura F; Ochiai T
    World J Surg; 2003 Mar; 27(3):289-93. PubMed ID: 12607053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases.
    Nagino M; Nimura Y; Nishio H; Ebata T; Igami T; Matsushita M; Nishikimi N; Kamei Y
    Ann Surg; 2010 Jul; 252(1):115-23. PubMed ID: 20531001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic features in patients with long-term survival following resection for intrahepatic cholangiocarcinoma.
    Uenishi T; Hirohashi K; Kubo S; Yamamoto T; Yamazaki O; Shuto T; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2003; 50(52):1069-72. PubMed ID: 12845984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additional resection of an intraoperative margin-positive proximal bile duct improves survival in patients with hilar cholangiocarcinoma.
    Ribero D; Amisano M; Lo Tesoriere R; Rosso S; Ferrero A; Capussotti L
    Ann Surg; 2011 Nov; 254(5):776-81; discussion 781-3. PubMed ID: 22042470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not?
    Miyazaki M; Kato A; Ito H; Kimura F; Shimizu H; Ohtsuka M; Yoshidome H; Yoshitomi H; Furukawa K; Nozawa S
    Surgery; 2007 May; 141(5):581-8. PubMed ID: 17462457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An intraductal papillary component is associated with prolonged survival after hepatic resection for intrahepatic cholangiocarcinoma.
    Tajima Y; Kuroki T; Fukuda K; Tsuneoka N; Furui J; Kanematsu T
    Br J Surg; 2004 Jan; 91(1):99-104. PubMed ID: 14716802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
    Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
    Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases.
    Shimada K; Sano T; Sakamoto Y; Esaki M; Kosuge T; Ojima H
    J Surg Oncol; 2007 Aug; 96(2):160-5. PubMed ID: 17443744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.
    Urahashi T; Yamamoto M; Ohtsubo T; Katsuragawa H; Katagiri S; Takasaki K
    Hepatogastroenterology; 2007 Mar; 54(74):346-9. PubMed ID: 17523271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.